Heuman D M, Pandak W M, Hylemon P B, Vlahcevic Z R
Department of Medicine, Medical College of Virginia, Richmond 23298.
Hepatology. 1991 Nov;14(5):920-6. doi: 10.1002/hep.1840140527.
Intraduodenal infusion of hydrophobic bile salts to bile-fistula rats leads within hours to severe hepatocellular necrosis and cholestasis; simultaneous administration of conjugates of ursodeoxycholate, either intraduodenally or intravenously, reduces or prevents liver injury. To evaluate the short-term protective effects of ursodeoxycholate at the cellular level, we incubated primary monolayer cultures of adult rat hepatocytes or freshly isolated washed human erythrocytes for 1 to 240 min with varying defined concentrations of different bile salts in the presence or absence of ursodeoxycholate. Cytolysis was quantified by measuring the release into the medium of cytosolic lactate dehydrogenase (hepatocytes) or hemoglobin (erythrocytes). In both systems, cytolysis increased sigmoidally with increasing bile salt concentration, and the relative toxicity of different bile salts proceeded in the following order: tauroursodeoxycholate was less toxic than taurocholate, which was less toxic than taurodeoxycholate. Taurochenodeoxycholate was more toxic to erythrocytes than taurodeoxycholate; the two were equally toxic to rat hepatocytes. Unconjugated bile salts were more toxic than their conjugates. The addition of tauroursodeoxycholate to taurochenodeoxycholate or taurodeoxycholate led to time-dependent and concentration-dependent reduction or elimination of the toxicity of the more hydrophobic component. Protection was evident within minutes. With respect to hemolysis, at pH 8.5 glyco was less protective than tauroursodeoxycholate, and free ursodeoxycholate was only minimally protective. We conclude that the hepatocytotoxicity of hydrophobic bile salts at millimolar concentrations is markedly reduced in the presence of tauroursodeoxycholate. Conjugates of ursodeoxycholate also prevented disruption of erythrocytes by bile salts, suggesting that protection does not depend on liver-specific pathways of bile salt uptake, compartmentation, transport or metabolism.(ABSTRACT TRUNCATED AT 250 WORDS)
向胆瘘大鼠十二指肠内输注疏水性胆盐会在数小时内导致严重的肝细胞坏死和胆汁淤积;同时经十二指肠或静脉给予熊去氧胆酸结合物可减轻或预防肝损伤。为了在细胞水平评估熊去氧胆酸的短期保护作用,我们将成年大鼠肝细胞的原代单层培养物或新鲜分离并洗涤过的人红细胞,在有或没有熊去氧胆酸存在的情况下,用不同定义浓度的不同胆盐孵育1至240分钟。通过测量胞质乳酸脱氢酶(肝细胞)或血红蛋白(红细胞)释放到培养基中的量来定量细胞溶解。在这两个系统中,细胞溶解均随胆盐浓度的增加呈S形增加,不同胆盐的相对毒性顺序如下:牛磺熊去氧胆酸的毒性低于牛磺胆酸,牛磺胆酸的毒性低于牛磺脱氧胆酸。牛磺鹅去氧胆酸对红细胞的毒性比牛磺脱氧胆酸更大;二者对大鼠肝细胞的毒性相同。未结合的胆盐比其结合物毒性更大。向牛磺鹅去氧胆酸或牛磺脱氧胆酸中添加牛磺熊去氧胆酸会导致更疏水成分的毒性随时间和浓度依赖性降低或消除。保护作用在数分钟内即可显现。关于溶血,在pH 8.5时,甘氨胆酸的保护作用不如牛磺熊去氧胆酸,游离熊去氧胆酸的保护作用微乎其微。我们得出结论,在存在牛磺熊去氧胆酸的情况下,毫摩尔浓度的疏水性胆盐的肝细胞毒性会显著降低。熊去氧胆酸结合物还可防止胆盐破坏红细胞,这表明保护作用不依赖于胆盐摄取、分隔、转运或代谢的肝脏特异性途径。(摘要截短至250字)